10-Q: Chemours Reports Q2 Loss Amidst Major PFAS Settlement

The Chemours Company reported a significant net loss for the second quarter and first half of 2025, primarily driven by a substantial settlement agreement with the State of New Jersey related to PFAS liabilities.

Summary

• Net loss attributable to Chemours was $381 million for the three months ended June 30, 2025, compared to net income of $60 million in the prior year period.
• Net loss attributable to Chemours was $385 million for the six months ended June 30, 2025, compared to net income of $113 million in the prior year period.
• Basic loss per share was $2.54 for Q2 2025 and $2.56 for H1 2025, a significant decline from earnings per share of $0.40 and $0.76 respectively in 2024.
• Net sales increased by $61 million (4%) to $1.615 billion for Q2 2025, driven by a 3% increase in volume and 1% in price.
• Net sales increased by $68 million (2%) to $2.983 billion for H1 2025, primarily due to a 4% increase in volume, partially offset by a 1% decrease in price and unfavorable currency movements.
• Selling, General, and Administrative (SG&A) expense surged by $283 million (over 100%) to $437 million for Q2 2025, mainly due to $257 million in litigation-related charges for the New Jersey settlement.
• Cash used for operating activities decreased significantly to $19 million for H1 2025, compared to $910 million used in H1 2024, primarily due to the release of restricted cash from a prior settlement.
• The company recorded a $119 million provision for income taxes in Q2 2025, including a $169 million tax expense for a valuation allowance against deferred tax assets, partially offset by a $66 million tax benefit related to environmental and litigation reserves.
• Total environmental remediation liabilities stood at $605 million as of June 30, 2025, with $102 million classified as current.

Sentiment

Score: 3

Explanation: The sentiment is predominantly negative due to a substantial net loss, driven by a large litigation settlement, and operational challenges in a key segment. While there are some positive trends in the Thermal & Specialized Solutions segment and efforts in sustainability, the overwhelming financial impact of legal liabilities and ongoing regulatory uncertainties significantly weigh down the overall outlook.

Positives

• Thermal & Specialized Solutions segment net sales increased by 15% in Q2 2025 and 9% in H1 2025, driven by stronger demand for Opteon™ Refrigerant blends due to the U.S. AIM Act regulatory transition.
• Thermal & Specialized Solutions Adjusted EBITDA increased by 29% in Q2 2025 and 12% in H1 2025, with margin expansion.
• Advanced Performance Materials segment saw a 6% price increase in Q2 2025, driven by high-value applications and pricing opportunities from the SPS Capstone™ exit.
• Corporate and Other costs decreased by $24 million (31%) in Q2 2025 and $22 million (17%) in H1 2025, primarily due to lower costs associated with the Audit Committee Internal Review.
• The company expects to release a portion of the valuation allowance recorded in Q2 2025 in Q3 2025 due to favorable changes in interest expense limitations from the newly enacted 'One Big Beautiful Bill Act'.
• The company believes it has sufficient liquidity through future cash flows, unrestricted cash, and revolving credit facility availability to meet current liabilities through at least August 2026.

Negatives

• The company reported a net loss of $381 million for Q2 2025 and $385 million for H1 2025, a significant reversal from net income in the prior year.
• Selling, General, and Administrative (SG&A) expense increased substantially due to a $257 million litigation charge related to the New Jersey settlement.
• Titanium Technologies segment net sales decreased by 3% in Q2 2025 and 1% in H1 2025, primarily due to a 4% decrease in price.
• Titanium Technologies Adjusted EBITDA decreased by 43% in Q2 2025 and 36% in H1 2025, with margin contraction, due to lower pricing and operational headwinds including a rail line service interruption and higher-cost ore feedstock.
• The company recorded a $169 million tax expense for a valuation allowance against deferred tax assets for U.S. federal and state interest carryforwards.
• Unscheduled downtime at Washington Works, West Virginia site in July 2025 due to a power outage and equipment damage is expected to result in lower sales and additional costs for the Advanced Performance Materials segment in Q3 2025.
• The company incurred $51 million in restructuring, asset-related, and other charges for H1 2025, primarily from exiting the SPS Capstone™ business and the Titanium Technologies Transformation Program.
• The company paid a €1 million penalty in June 2025 related to F-gas reporting at its Dordrecht Works facility, with an objection submitted.

Risks

• Adverse resolution of one or more legal or environmental matters could have a material adverse effect on liquidity.
• The company is subject to extensive environmental and health and safety laws and regulations, which may result in unanticipated loss or liability, significant additional compliance costs, or restrictions on operations.
• Changes in laws, science, or regulations, or their interpretations, and customer perception of such changes, may affect the marketability of certain products, particularly PFAS-containing products.
• The ultimate costs under environmental laws and the timing of these costs are difficult to accurately predict, and actual costs may vary from accruals due to unknown environmental conditions, changing regulations, and other factors.
• There is a risk that the outcome of technical evaluations in the New Jersey settlement's RFS review process could lead to additional required remediation activities and future changes to environmental reserve estimates.
• Potential future litigation and/or regulatory demands regarding Fayetteville discharges, including permit modifications or penalties, could arise.
• The timing of remaining TSCA test orders for PFAS compounds is not determinable, and additional costs could be incurred.
• The ultimate outcome of EPA actions regarding PFAS, including new drinking water standards and CERCLA designation, could materially increase environmental remediation liabilities and accrued litigation.
• Significant regional or national differences in approaches to environmental regulations could present competitive challenges or opportunities in a global marketplace.
• The long-term impact of tariffs on the business, financial condition, and results of operations remains uncertain.
• Borrowing costs can be impacted by shortand long-term debt ratings, which could constrain capital availability or increase funding costs.
• The company is exposed to foreign currency exchange rate changes, interest rate risk, and commodity price changes, which may impact future cash flows and earnings.

Future Outlook

The company anticipates generating additional positive cash flows from operations in 2025 and expects sufficient liquidity to support cash needs through at least August 2026. A portion of the valuation allowance recorded in Q2 2025 is expected to be released in Q3 2025 due to favorable tax law changes. The company continues to implement abatement technology at Dordrecht Works to reduce discharges below conditional fine levels. The appeal regarding EPA's NPDWR for PFAS and CERCLA designation of PFOA/PFOS are held in abeyance, with potential for increased environmental liabilities depending on the outcome. The company is committed to its 2030 sustainability goals, including a 60% reduction in Scope 1 and 2 GHG emissions and a 25% reduction in Scope 3 emissions per ton of product, and aims for net zero GHG emissions by 2050.

Management Comments

• We are a different kind of chemistry company. Our world-class product portfolio enables the performance and convenience of everyday products, processes, and technologies people rely on in their daily lives, making our products and the solutions they enable both vital and essential.
• We are committed to creating value for our customers and stakeholders by leveraging strengths that we use to create competitive advantage: our innovation and technical expertise, our ability to operate complex manufacturing sites safely, our deep customer relationships based on trust and reliability, and our talented workforce.
• Our core values, in unison with our company vision of Trusted Chemistry, helping people live better lives and communities thrive, underpin our commitment to our stakeholders. Our values and vision cannot be separated from our business strategy.
• At Chemours, our approach to Sustainability begins with our vision to deliver Trusted Chemistry that helps people live better lives and communities to thrive. That vision calls on us to ensure that our decisions ultimately help people live better lives and communities thrive.
• We don't embrace sustainability for the sake of it, we ensure that our work is a fully integrated part of delivering our corporate strategy, Pathway to Thrive.
• Through sustainability we are actively protecting our license to operate our facilities, meeting the needs of our customers and differentiating our portfolio, advancing the work across the four pillars of our strategy – Operational Excellence, Enabling Growth, Portfolio Management, and Strengthening the Long-Term – to create value for our shareholders.
• We believe that climate change is an important global issue that presents both opportunities and challenges for our company, our partners, our customers, and our communities.
• We are a proponent of the AIM Act, which went into effect in 2022 and has begun the national phase-down of hydrofluorocarbons.
• We successfully completed an improvement project to significantly reduce emissions of HFC-23 at our Louisville, Kentucky manufacturing site.
• We are on track to achieve, by the end of 2025, our estimated goal that our low GWP products will result in 325 million tons of avoided emissions of carbon dioxide equivalents on a global basis.
• Management does not believe that any loss, in excess of amounts accrued, related to remediation activities at any individual site will have a material impact on our financial position or cash flows for any given year, as such obligation can be satisfied or settled over many years.

Industry Context

The chemical sector, particularly companies involved with fluorinated compounds, faces increasing regulatory scrutiny and litigation related to PFAS. Chemours' significant legal settlements and ongoing environmental remediation efforts reflect this industry-wide challenge. The company's focus on its Opteon™ portfolio aligns with global regulations (e.g., U.S. AIM Act, EU F-Gas Directive) driving the phase-down of high global warming potential (GWP) refrigerants, positioning it to capitalize on the transition to lower GWP alternatives. However, the Titanium Technologies segment faces headwinds from pricing and operational issues, indicating broader market or supply chain challenges in that specific product area. The company's investment in clean energy technologies like EV batteries and hydrogen generation also positions it within the growing green economy trend.

Comparison to Industry Standards

• Chemours' Opteon™ portfolio of low GWP refrigerants is designed to meet global regulations like the U.S. AIM Act and EU F-Gas Directive, similar to how other chemical companies like Honeywell (Solstice®) and Daikin (HFO-1234yf) are developing and marketing next-generation refrigerants to comply with environmental mandates and capture market share in the transition away from high-GWP HFCs.
• The company's commitment to a 60% reduction in Scope 1 and 2 GHG emissions by 2030 and net zero by 2050 aligns with ambitious sustainability targets set by industry peers such as DuPont and 3M, who are also investing in sustainable manufacturing processes and product portfolios to address climate change concerns and meet stakeholder expectations.
• The substantial PFAS-related litigation and environmental liabilities, including the $875 million New Jersey settlement, are indicative of the significant legal and financial challenges faced by legacy chemical manufacturers (e.g., DuPont, 3M) with historical involvement in PFAS production or use, setting a precedent for potential future liabilities across the industry.
• The operational disruptions in the Titanium Technologies segment, such as the rail line service interruption and reliance on higher-cost ore feedstock, highlight supply chain vulnerabilities common in commodity chemical sectors, which can impact profitability similar to challenges faced by other TiO2 producers like Tronox or Venator.

Legal Proceedings

• **New Jersey Settlement:** Chemours, DuPont, Corteva, and EID agreed to a proposed Judicial Consent Order (JCO) with the State of New Jersey to resolve all statewide PFAS claims and legacy contamination claims at four sites (Chambers Works, Parlin, Pompton Lakes, Repauno). The settlement involves scheduled annual payments totaling $875 million over 25 years, with Chemours contributing 50% (NPV of $257 million).
• **PFAS Insurance Proceeds MOU:** Contingent on the New Jersey settlement, Chemours assigned rights to certain insurance proceeds to other parties in return for $150 million to fund its share of the New Jersey settlement. This also suspends certain future MOU escrow payments.
• **Asbestos Litigation:** Approximately 815 lawsuits pending against EID (assigned to Chemours) alleging personal injury from asbestos exposure. Chemours assumed approximately 20 current and all future SGPI asbestos and product liability claims as part of a March 2025 settlement with EID.
• **Benzene Litigation:** 22 cases pending against EID (assigned to Chemours) alleging benzene-related illnesses. A 50/50 distribution of available escrow funds from insurance settlements resulted in Chemours receiving $20 million.
• **PFOA Matters (Leach Settlement):** Ongoing obligations related to the 2004 Leach v. DuPont class action, including funding a medical monitoring program and providing water treatment. Accrual of $39 million at June 30, 2025.
• **PFOA Leach Class Personal Injury:** All MDL lawsuits resolved through prior settlements, but approximately 96 plaintiffs filed matters after the First MDL Settlement. A settlement for 45 filed and 29 pre-suit claims for $58.5 million (Chemours' share $29.25 million) was finalized in November 2024, closing the MDL.
• **Aqueous Film Forming Foam (AFFF) Matters:** Approximately 7,850 matters pending, mostly in a multi-district litigation (AFFF MDL). Chemours, Corteva/EID, and DuPont entered into a U.S. public water system class action settlement agreement in June 2023 for $1.185 billion (Chemours' 50% share funded). Ongoing discovery for non-water provider cases, with a first Tier 2 Group A trial set for October 2025.
• **Other Public Water System Matters:** Numerous lawsuits filed by public water systems and landowners across various states (New York, New Jersey, Georgia, Alabama, South Carolina, Montana, Pennsylvania) alleging PFAS contamination from industrial discharges, carpet manufacturing, or AFFF, seeking compensatory and punitive damages, and injunctive relief. Many of these entities opted out of the U.S. public water system class action settlement.
• **State Natural Resource Damages Matters:** Majority of U.S. states and territories are investigating or have filed lawsuits against various defendants, including Chemours, for alleged PFAS contamination of natural resources. Settlements reached with Ohio ($55 million, Chemours' 50% share) and Delaware ($50 million total, Chemours' $25 million share, plus a $13 million supplemental payment).
• **Hoosick Falls Class Action:** Agreement in principle reached to resolve the class action for $27 million (Chemours' portion $13.5 million), with initial payment after court approval and subsequent annual installments.
• **Dordrecht Works, Netherlands:** Civil summons from four municipalities seeking liability declarations for Dordrecht site operations and emissions. Court ruled defendants liable for PFOA emissions and removal costs. Ongoing discussions for a specific remediation plan and potential settlement fund. Dutch criminal complaint filed against Chemours and directors for alleged unlawful emissions.
• **Dutch ILT Agency Penalty:** Company paid a €1 million penalty in June 2025 related to F-gas reporting at Dordrecht Works, with an objection submitted. European Commission also sent compliance letters alleging F-gas regulation infringement and quota exceedance.
• **U.S. Smelter and Lead Refinery, Inc.:** Five lawsuits pending in Indiana federal court, including a putative class action, concerning a Superfund site, alleging Chemours is responsible for EID environmental liabilities.
• **Securities Related Litigation:** Two putative class actions filed in Delaware federal court against the company and former officers alleging violations of the Securities Exchange Act of 1934. Multiple stockholder demands for inspection of books and records. Two stockholder derivative actions filed and consolidated/stayed, with a third filed in June 2025.
• **West Virginia Rivers Coalition vs. Washington Works:** Complaint filed under the Clean Water Act alleging ongoing exceedances of effluent discharge limits for PFOA and HFPO Dimer Acid. Motion for preliminary injunction filed, and trial date moved.

Related Party Transactions

• Net sales to equity method investees amounted to $69 million for the six months ended June 30, 2025, and purchases from equity method investees amounted to $153 million for the same period.
• The Memorandum of Understanding (MOU) with DuPont, Corteva, and EID outlines a cost-sharing arrangement for potential future legacy PFAS liabilities arising from pre-July 1, 2015 conduct, with Chemours bearing half the cost up to an aggregate of $4 billion.
• The PFAS Insurance Proceeds Memorandum of Understanding (MOU) involves Chemours assigning rights to certain insurance proceeds to DuPont and Corteva in return for $150 million to fund a portion of Chemours' share of the New Jersey settlement.
• Chemours has indemnification and expense advancement obligations pursuant to its bylaws and indemnification agreements with respect to certain current and former members of senior management and directors, incurring $1 million in costs for these requests during H1 2024.

Stakeholder Impact

• **Shareholders:** Significant net loss and negative EPS will negatively impact shareholder value. The large New Jersey settlement and ongoing litigation create financial uncertainty and potential for future liabilities, impacting investor confidence. Dividend declared ($0.0875 per share) indicates continued commitment to returning capital, but at a reduced rate compared to prior periods ($0.25 per share in Q2 2024).
• **Employees:** Restructuring programs (SPS Capstone™ Exit, 2024 Restructuring Program, Titanium Technologies Transformation Plan) involve employee separation charges, indicating job reductions in certain areas. Stock-based compensation plans are in place to incentivize management and employees.
• **Customers:** Operational disruptions in the Titanium Technologies segment (e.g., rail line interruption) could impact product supply and lead to higher costs for customers. The company's focus on Opteon™ refrigerants aims to meet customer demand for low GWP solutions driven by regulatory changes.
• **Communities:** Significant environmental remediation efforts and legal settlements related to PFAS contamination (e.g., New Jersey, Fayetteville, Dordrecht) directly impact the health and environment of surrounding communities. The company's commitment to sustainability and reducing emissions aims to improve community relations and environmental stewardship.
• **Creditors:** Increased long-term debt and significant accrued liabilities, particularly for litigation and environmental remediation, could impact the company's credit profile. Compliance with debt covenants is crucial for maintaining access to financing.

Next Steps

• Continue to assess the full impact of the 'One Big Beautiful Bill Act' on consolidated financial statements.
• Work with NJ DEP and potentially LSRPs to determine appropriate Remediation Funding Source (RFS) amounts and review future scope of remediation for the four sites covered by the New Jersey settlement.
• Continue to engage with regulatory authorities on the revised permit application for Dordrecht Works.
• Continue to implement abatement technology at Dordrecht Works to reduce discharges below conditional fine levels.
• Monitor EPA actions related to PFAS under the new administration, including TSCA testing strategy and Effluent Limitations Guidelines.
• Continue to progress discussions with EPA regarding PFAS-related allegations at sites, including the February 2019 NOV.
• Proceed with discovery in certain personal injury cases within the AFFF MDL, with Tier 2 discovery for Group B cases to be completed by September 2025.
• Engage in discussions with a mediator for potential resolution of personal injury cases in the AFFF MDL.
• Proceed with product identification discovery on a selection of 12 real property cases in the AFFF MDL, with fact discovery set to be completed in November 2025.
• Continue to develop and upgrade the Local landfill cover at Washington Works.
• Continue to assess future stormwater discharges and permitting at Washington Works.
• Continue to engage with the public prosecutor in the Netherlands regarding the alleged criminal offense related to the Netherlands Environmental Management Act and Working Conditions Decree.
• Continue to evaluate the potential impact of new F-Gas reporting and quota consumption regulations.
• Continue to monitor the public consultation period on the CLH proposal for TFA and the subsequent review by ECHA's Risk Assessment Committee (RAC) and Socio-economic Analysis Committees (SEAC).
• Continue to work with the municipalities of Dordrecht, Papendrecht, Sliedrecht, and Molenlanden to identify actions that may resolve community concerns and further settlement discussions.
• Attend a further hearing in August 2025 for the West Virginia Rivers Coalition lawsuit against Washington Works after the trial was taken off schedule.

Key Dates

Recommendation

The company reported a substantial net loss for the quarter and year-to-date, primarily driven by a massive $257 million litigation charge for the New Jersey PFAS settlement. This, coupled with ongoing significant environmental liabilities (totaling $605 million) and a multitude of other unresolved PFAS, asbestos, and benzene lawsuits, presents a highly uncertain and financially burdensome outlook. While the Thermal & Specialized Solutions segment shows some growth, the Titanium Technologies segment is underperforming due to operational issues and pricing pressure. The company's liquidity, while currently sufficient, is heavily reliant on future operating cash flows and potential refinancing, which could be impacted by market conditions and its credit ratings. The 'One Big Beautiful Bill Act' might offer some tax relief, but it's insufficient to offset the immediate and long-term financial strain from legal and environmental obligations. The sheer scale of the liabilities and the inherent unpredictability of litigation outcomes suggest significant downside risk, making the stock a 'sell' for a seasoned investor.

Keywords

Chemicals, Specialty Chemicals, Fluoropolymers, Refrigerants, Titanium Dioxide, PFAS, Environmental Remediation, Litigation, SEC Filing, 10-Q, Financial Results, Sustainability, Corporate Governance, Risk Management